New Merck and Moderna vaccine extends lifespan of people living with deadliest form of skin cancer

New Merck and Moderna vaccine extends lifespan of people living with deadliest form of skin cancer

Moderna‘s experimental vaccine that nearly halves the risk of skin cancer returning in high-risk patients is one step closer to becoming an approved treatment.  The shot, called Intismeran, is combined …

New Merck and Moderna vaccine extends lifespan of people living with deadliest form of skin cancer اقرأ المزيد